EDGAR Filing Documents for 0001485003-17-000140

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:

SEC Accession No. 0001485003-17-000140

Filing Date

2017-11-15

Accepted

2017-11-15 08:15:46

Documents

Period of Report

2017-09-30

Effectiveness Date

2017-11-15

Document Format Files

Seq	Description	Document	Type	Size
1	NT 10-Q	ebio-form12bx25noticeforqu.htm	NT 10-Q	64476
	Complete submission text file	0001485003-17-000140.txt		65503

Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142

Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550

Eleven Biotherapeutics, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | Fiscal Year End: 1231
Type: NT 10-Q | Act: 34 | File No.: 001-36296 | Film No.: 171203928
SIC: 2834 Pharmaceutical Preparations